Calamos Advisors LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$1,516,000
-67.5%
11,947
-71.9%
0.01%
-72.0%
Q1 2021$4,662,000
-48.7%
42,494
-33.2%
0.02%
-52.8%
Q4 2020$9,089,000
+136.3%
63,661
+16.8%
0.05%
+112.0%
Q3 2020$3,847,000
+2.7%
54,517
+1.9%
0.02%
-3.8%
Q2 2020$3,745,000
+207.7%
53,505
+53.7%
0.03%
+160.0%
Q1 2020$1,217,000
-64.2%
34,821
-35.7%
0.01%
-41.2%
Q4 2019$3,403,00054,1350.02%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders